Kilter Group’s Medpace MEDP Stock Holding History

Kilter Group’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$30.7K	Buy	58 +30	+107%	+$13.8K	0.01%	194
2026 Q1	$13.4K	Buy	+28	New	+$14.3K	0.01%	313
2025 Q3	–	Sell	-8	Closed	-$2.51K	–	1288
2025 Q2	$2.51K	Buy	+8	New	+$2.4K	﹤0.01%	556

Other funds holding MEDP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Kilter Group's MEDP Position: Q2 2026 in Review

Kilter Group increased its Medpace (MEDP) stake by 107% in Q2 2026, buying an estimated $13.8K and bringing the position to 58 shares worth $30.7K. The position accounts for 0.01% of the portfolio, ranked #194.

Kilter Group first reported a position in MEDP in Q2 2025 and has held it in 3 quarters since. 700 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

Kilter Group held 58 shares of Medpace worth $30.7K as of Q2 2026.
Kilter Group bought 30 Medpace shares in Q2 2026, an estimated $13.8K.
Medpace made up 0.01% of Kilter Group's portfolio in Q2 2026, its #194 holding.
Kilter Group first reported a position in Medpace in Q2 2025 and has held it in 3 quarters since.
700 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Kilter Group's 13F filing for Q2 2026, filed 11 Aug 2026.